Skip to main content
SpringerLink
Log in

Antipsychotics: Neurophysiological Properties (in Man)

  • Chapter
Psychotropic Agents

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 55 / 1))

Abstract

Antipsychotics (neuroleptics) introduced the era of psychopharmacology and quite early on, as soon as favorable clinical activity had been ascertained, their neurophysiological properties were intensively explored. Compared to the well known EEG profiles of previously used psychoactive substances, e.g., barbiturates, opioids, stimulants, and psychodysleptics, the new antipsychotics proved to possess very clear-cut profiles.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aghajanian, J., Bunney, B.: Dopaminergic neurons of the substantia nigra. J. Pharmacol. Exp. Ther.5 (Suppl. 1), 58 (1974)

    Google Scholar 

  • Bartholini, G.: Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system. J. Pharm. Pharmacol. 28, 429–433 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Berger, H.: Über das Electroenzephalogramm des Menschen. Arch. Psychiatr. Nervenkr. 87, 527–570 (1929)

    Article  Google Scholar 

  • Borenstein, P., Cujo, P., Chiva, M.: A propos de la classification des substances psychotropes selon leurs effects sur l’EEG. Ann. Med. Psychol. 2, 429–452 (1965)

    Google Scholar 

  • Brazier, M.: The application of computers to EEG. In: Computers in Biomedical Research Brazier, M. (ed.) Vol.1, pp. 2–9. New York: Academic Press 1965

    Google Scholar 

  • Carlsson, A.: Receptor-mediated control of dopamine synthesis. J. Pharmacol. (Suppl. 1), 5, 58 (1974)

    Google Scholar 

  • Christensen, A., Fjalland, B., Moller-Nielsen, T.: On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 48, 1–6 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Ciganek, L.: Die EEG Lichtreizantwort der menschlichen Hirnrinde. S.A.V. Bratislava (1961)

    Google Scholar 

  • Curry, S.: Chlorpromazine: concentration in plasma, excretion in urine and duration effect. Proc. R. Soc. Med.64, 285–289 (1971)

    PubMed  CAS  Google Scholar 

  • Domino, E.: Sites of action of some central nervous system depressants. Annu. Rev. Pharmacol., 215–268 (1962)

    Google Scholar 

  • Fink, M.: EEG and behavioral effects of psychopharmacologic agents. Neuropsychopharma-cology 7, 441–446 (1961)

    Google Scholar 

  • Fink, M.: EEG and Human Psychopharmacology. Annu. Rev. Pharmacol.9, 241–258 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Fink, M.: EEG profiles and bioavailability measures of psychoactive drugs. In: Modern Problems of Pharmacopsychiatry (Itil, T., ed.), Vol. VIII pp. 76–98. Basel: Karger 1974

    Google Scholar 

  • Fink, M.: Prediction of clinical activity of psychoactive drugs: Application of cerebral elec-trometry in phase I studies. In: Predictability in Psychopharmacology (Sudilowsky, A., Gershon, S., Beer, B., eds) New York; pp. 65–88. Raven Press 1975

    Google Scholar 

  • Guillemin, R., Ling, N., Burgus, R.: Endorphines, peptides d’origine hypothalamique et neuro-hypophysaire a activité morphinométique. Isolement et structure molèculaire d’α-endor-phine. Cr. hebd. Séanc. Acad. Sci. Paris, Sér. D, 282, 783–785 (1976)

    CAS  Google Scholar 

  • Itil, T.M., Keskiner, A., Fink, M.: Therapeutic studies in “therapy resistant” schizophrenic patients. Compr. Psychiatry, 7, 488–493 (1966)

    Article  PubMed  CAS  Google Scholar 

  • Itil, T.M.: EEG and Pharmacopsychiatry. In: Clinical Pharmacology (Freyhan, F., ed.), pp. 163–194. Basel: Karger 1968

    Google Scholar 

  • Itil, T.M., Hsu, W., Saletu, B., Mednick, S.: Computer EEG and evoked potential investigations in children of high risk for schizophrenia. Am. J. Psychiatry 131, 892–900 (1974)

    PubMed  CAS  Google Scholar 

  • Itill, T.M.,: Digital computer period analyzed EEG in psychiatry and psychopharmacology. In: Computerized EEG Analysis (Dolce, G., Künkel, H., eds.) pp. 289–308. Stuttgart: Fischer 1975

    Google Scholar 

  • Klik, J.: Experience with clozapine in psychiatric practice. Cesk. Psychiatr. 72, 197 (1976)

    CAS  Google Scholar 

  • Kline, N.S., Li, C.H., Lehmann, H.E., Lajtha, A., Laski, E., Cooper, T.: β-Endorphin-induced changes in schizophrenic and depressed patients. Arch. Gen. Psychiatry, in print (1977)

    Google Scholar 

  • Kogan, W., Nikolenko, N.: New drugs and the treatment of nervous and mental diseases. Report of Leningrad Bechterev Psychoneurol. Inst. 40 (1974)

    Google Scholar 

  • Kosterlitz, H., Hughes, J.: Peptides with morphine-like action in the brain. Br. J. Psychiatry 130, 298–304 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Matousek, M.: Automatic analysis in clinical EEG. Psychiatr. Research Inst., Prague (1967)

    Google Scholar 

  • Matousek, M., Roubicek, J., Vinar, O., Roth, J.: Klinische und electroencephalographische Kriterien der Auswahl der optimalen Medikation. Arzneim.-Forsch. 19, 438 (1969)

    Google Scholar 

  • Nahunek, K., Svestka, J., Misurec, J., Radova, A.: Experiences with clozapine. Cesk. Psychiatr. 71, 11 (1975)

    CAS  Google Scholar 

  • Roemer, D., Buescher, H.H., Hill, R.C., Pless, J., Bauer, W., Cardinaux, F., Closse, A., Hauser, D., Huguenin, R.: A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature 268, 547–549 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Roubicek, J.: Experimental psychoses. Cesk. Psychiatr., 57, 420–422 (1961)

    Google Scholar 

  • Roubicek, J., Major, I.: EEG profile and behavioral changes after a single dose of clozapine in normals and in schizophrenics. Biol. Psychiatry 12, 613–633 (1977)

    PubMed  CAS  Google Scholar 

  • Roubicek, J., Srnec, J.: Experimental psychosis LSD. Cas. Lek. Cesk. 94, 189 (1955)

    PubMed  CAS  Google Scholar 

  • Roubicek, J., Matejcek, M., Porsolt, R.: Computer analyzed EEG and behavioral changes after psychoactive drugs. Int. J. Neurol. 10, 33 (1975)

    PubMed  CAS  Google Scholar 

  • Saletu, B.: Classification of psychotropic drugs based on human evoked potentials. In: Psychotropic Drugs and the Human EEG (Itil, T., ed). Basle: Karger 1974

    Google Scholar 

  • Saletu, B.: Psychopharmaka, Gehirntätigkeit und Schlaf. Basle: Karger 1976 Shagass, C.: Effects of psychotropic drugs in human evoked potentials. In: Psychotropic Drugs and the Human EEG (M, T., ed.), Vol. VIII, pp. 238–257. Basle: Karger 1974

    Google Scholar 

  • Shaw, J., O’Connor, P., Ongley, C.: The EEG as a measure of cerebral functional organization. Br. J. Psychiatry 130, 260–264 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Sulser, F., Stewart, R., Blumberg, T.: The limbic forebrain: The role of catecholamines in the action of antipsychotics. J. Pharmacol. Exp. Ther. 5, (Suppl. 1), 155 (1974)

    Google Scholar 

  • Walter-Grey, W., Cooper, R., Aldridge, V., McCallum, W., Winter, A.: Contingent negative variation. Nature 203, 380–384 (1964)

    Article  Google Scholar 

  • Wikler, A.: Clinical and electroencephalographic studies on the effects of mescaline, N-allylor-morphine and morphine in man. J. Nerv. Ment. Dis. 120, 157–175 (1954)

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Roubicek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Bayer AG, Aprather Weg 18a, D-5600, Wuppertal 1, Germany

    F. Hoffmeister

  2. Institut für Arzneimittel des Bundesgesundheitsamtes, StauffenbergstraÜe 13, D-100, Berlin 30, Germany

    G. Stille

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roubicek, J. (1980). Antipsychotics: Neurophysiological Properties (in Man). In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67538-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67538-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67540-9

  • Online ISBN: 978-3-642-67538-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation